PI
VRTX icon

PGGM Investments’s Vertex Pharmaceuticals VRTX Stock Holding History

PGGM Investments’s Portfolio VRTX Stock Details VRTX Fund Activity
Bought
Maintained
Sold
Quarter Market Value Status Shares Change in
Stake 		Trade Value Portfolio Weight Portfolio Position
2024
Q3 		– Sell
-3,937
Closed -$1.84M – 366
2024
Q2 		$1.84M Sell
3,937
-2,354
-37% -$1.02M 0.03% 260
2024
Q1 		$2.63M Sell
6,291
-122
-2% -$51.6K 0.04% 248
2023
Q4 		$2.61M Buy
6,413
+3,018
+89% +$1.11M 0.04% 252
2023
Q3 		$1.18M Buy
3,395
+2,183
+180% +$763K 0.02% 294
2023
Q2 		$427K Buy
+1,212
New +$408K 0.01% 335
2023
Q1 		– Sell
-7,896
Closed -$2.28M – 405
2022
Q4 		$2.28M Sell
7,896
-3,200
-29% -$975K 0.04% 276
2022
Q3 		$3.21M Buy
+11,096
New +$3.19M 0.06% 250
2021
Q3 		– Sell
-963
Closed -$194K – 437
2021
Q2 		$194K Buy
+963
New +$201K ﹤0.01% 388
2020
Q4 		– Sell
-274,529
Closed -$74.7M – 361
2020
Q3 		$74.7M Buy
274,529
+109,698
+67% +$30.3M 0.39% 65
2020
Q2 		$47.9M Buy
+164,831
New +$44.7M 0.28% 87

Other funds holding VRTX

Capital World Investors
Capital World Investors Los Angeles, California $733B AUM 35.63% 1-Year Est. Return
Vanguard Group
Vanguard Group Malvern, Pennsylvania $6.9T AUM 27.45% 1-Year Est. Return
BlackRock
BlackRock New York $5.72T AUM 30.48% 1-Year Est. Return
State Street
State Street Boston, Massachusetts $2.9T AUM 29.55% 1-Year Est. Return
Fidelity Investments
Fidelity Investments Boston, Massachusetts $1.9T AUM 41.92% 1-Year Est. Return
Capital Research Global Investors
Capital Research Global Investors Los Angeles, California $645B AUM 30.41% 1-Year Est. Return
AllianceBernstein
AllianceBernstein Nashville, Tennessee $309B AUM 23.92% 1-Year Est. Return
JP Morgan Chase
JP Morgan Chase New York $1.56T AUM 27.86% 1-Year Est. Return
Geode Capital Management
Geode Capital Management Boston, Massachusetts $1.61T AUM 30.72% 1-Year Est. Return
Jennison Associates
Jennison Associates New York $145B AUM 34.61% 1-Year Est. Return

PGGM Investments's VRTX Position: Q3 2024 in Review

PGGM Investments sold out of Vertex Pharmaceuticals (VRTX) in Q3 2024, closing a stake of 3,937 shares — an estimated $1.84M sold.

PGGM Investments first reported a position in VRTX in Q2 2020 and held it in 10 quarters. The position peaked at $74.7M in Q3 2020. 1,544 funds tracked by Wall St. Rank hold VRTX as of Q3 2024.

  • PGGM Investments reported no remaining Vertex Pharmaceuticals position as of Q3 2024 after selling out during the quarter.
  • PGGM Investments sold 3,937 Vertex Pharmaceuticals shares in Q3 2024, an estimated $1.84M.
  • PGGM Investments first reported a position in Vertex Pharmaceuticals in Q2 2020 and held it in 10 quarters.
  • PGGM Investments's Vertex Pharmaceuticals position peaked at $74.7M in Q3 2020.
  • 1,544 funds tracked by Wall St. Rank held Vertex Pharmaceuticals as of Q3 2024.

Based on PGGM Investments's 13F filing for Q3 2024, filed 13 Nov 2024.